COVID-19: SAHPRA to facilitate controlled access to Ivermectin

File: Details of the programme will be revealed soon. AFP/Luis Robayo

JOHANNESBURG - The South African Health Products Regulatory Authority (SAHPRA) has resolved to facilitate controlled access to Ivermectin for COVID-19 treatment.

SAHPRA says it will be engaging with medical professionals and a guideline will be published soon.

There has been much debate around the use of the drug.

South Africa's COVID-19 death toll is 41,797.

Confirmed COVID-19 cases are now over 1.4 million.

Source
eNCA

Paid Content